Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression

Leonardo Delello Di Filippo, Jonatas Lobato Duarte, Juliana H. Azambuja, Rubia Isler Mancuso, Marcela Tavares Luiz, Victor Hugo Sousa Araújo, Ingrid Delbone Figueiredo, Lucas Barretto‐de‐Souza, Rafael Miguel Sábio, Estela Sasso‐Cerri, Amanda Martins Baviera, Carlos C. Crestani, Sara T.O. Saad, Marlus Chorilli